- Patent Title: HGF preparation suitable for treatment of neurological disorders
-
Application No.: US15507886Application Date: 2015-08-27
-
Publication No.: US10213485B2Publication Date: 2019-02-26
- Inventor: Kazuhiro Fukuta , Hayao Inoue
- Applicant: KRINGLE PHARMA INC.
- Applicant Address: JP Osaka
- Assignee: KRINGLE PHARMA INC.
- Current Assignee: KRINGLE PHARMA INC.
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2014-184475 20140910
- International Application: PCT/JP2015/074310 WO 20150827
- International Announcement: WO2016/039163 WO 20160317
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61K38/22 ; A61K47/02 ; A61K47/12 ; A61K47/26 ; A61K9/08 ; A61K9/19 ; A61K9/00 ; A61K47/18 ; A61P9/10 ; A61P25/16 ; A61P25/14 ; A61P25/28

Abstract:
The present invention provides a hepatocyte growth factor (HGF) preparation in the form of an injection or the like that is highly safe for central nerves and highly stable and can be used for intrathecal or intracerebroventricular administration or for administration into the spinal or cerebral parenchyma for the treatment of central nervous system diseases. The HGF preparation of the present invention contains an HGF protein as an active ingredient and lactose, glycine, sodium chloride, a pH buffering agent and a surfactant as additional ingredients.
Public/Granted literature
- US20170333527A1 HGF PREPARATION SUITABLE FOR TREATMENT OF NEUROLOGICAL DISORDERS Public/Granted day:2017-11-23
Information query
IPC分类: